Scalper1 News
Natera (NTRA) received a warm welcome Thursday with an initial public offering that jumped at the opening. Natera raised $180 million, offering 10 million shares at 18, the high end of its expected range. Natera stock was up 25%, above 22, in midday trading on the stock market today. Natera develops non-invasive prenatal disease screening tests and oncology therapeutic monitoring. In March 2013, Natera launched Panorama, which can measure genomic Scalper1 News
Scalper1 News